Association of miltefosine with granulocyte and macrophage colony-stimulating factor (GM-CSF) in the treatment of cutaneous leishmaniasis in the Amazon region: A randomized and controlled trial

Association of miltefosine with granulocyte and macrophage colony-stimulating factor (GM-CSF) in the treatment of cutaneous leishmaniasis in the Amazon region: A randomized and controlled trial

Objectives: To compare topical granulocyte and macrophage colony-stimulating factor (GM-CSF) and miltefosine (G + M) versus placebo and miltefosine (P + M) or parenteral meglumine antimoniate (MA) in the treatment of 150 patients with cutaneous leishmaniasis (CL) caused by Leishmania guyanensis in t...

Full description

Bibliographic Details
Main Authors: Luciana Mendes, Jorge Oliveira Guerra, Bleno Costa, Aríneia Soares da Silva, Maria das Graças Barbosa Guerra, Jéssica Ortiz, Susan Smith Doria, George Villarouco da Silva, Denison Vital de Jesus, Manoel Barral-Netto, Gerson Penna, Edgar M. Carvalho, Paulo R.L. Machado
Format: Article
Language:English
Published: Elsevier 2021-02-01
Series:International Journal of Infectious Diseases
Subjects:
Cutaneous leishmaniasis
GM-CSF
Miltefosine
Meglumine antimoniate
L. guyanensis
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971220324966

Internet

http://www.sciencedirect.com/science/article/pii/S1201971220324966

Similar Items